Medtronic beats quarterly profit estimates on robust demand for heart devices | ReutersSkip to main content[Exclusive news, data and analytics for financial market professionalsLearn more aboutRefinitiv]A general view of the logo of Medtronic, a healthcare technology and pharmaceutical company, at their plant, in Galway, Ireland, April 11, 2025. REUTERS/Clodagh Kilcoyne/File Photo [Purchase Licensing Rights, opens new tab]- Companies[Medtronic Inc]Follow[Abbott Laboratories]Follow[Dexcom Inc]FollowShow more ...

Core Insights - Baird Medical has received regulatory approval to expand its operations in Indonesia, emphasizing its commitment to enhancing patient care through innovative, minimally invasive technologies [1][3] - The company specializes in microwave ablation (MWA), a precise and effective procedure for treating conditions like thyroid nodules and tumors, known for its minimal impact on surrounding tissues and faster recovery times [2][4] - Baird Medical aims to strengthen its distribution network and collaborate with key medical institutions in Indonesia, reinforcing its strategy to introduce next-generation medical solutions to emerging markets [3][4] Company Overview - Baird Medical is a medical device company focused on minimally invasive diagnostics and treatments, dedicated to the research and development of AI-powered surgical robotic systems and innovative surgical instruments [4] - The company has deployed its solutions in over 30 prestigious hospitals and clinics in the United States, including renowned institutions like Johns Hopkins Hospital and Weill Cornell Medicine [4] - Baird Medical is a market leader in China for thyroid microwave ablation devices and is expanding its commercial presence in over 20 countries worldwide [4]